Register | Forgot password?
Switch to Arabic
Wednesday, November 11 - 2009
Page navigation Browse related articles

Mental health needs outweigh resources in Middle East

  • United Arab Emirates: Thursday, October 09 - 2008 at 15:33
  • PRESS RELEASE

According to the 2008 report issued by the World Federation for Mental Health (WFMH), the best way to change the stigma associated with mental illness is advocacy.

Article continues below
 
The document is intended to provide communities, patients, families and healthcare professionals with the tools to make a difference as part of World Mental Health Day today.

It also paints a grim picture of the support services available to the 450 million people who suffer from mental illness around the world; nearly 12% of the world's population.

Despite the overwhelming number of people affected, mental illnesses such as depression, dementia and schizophrenia, as well as mental health services and the promotion of mental well-being, do not receive the same attention and funding as other disorders and health issues.

Services in the developing world, including the Middle-East, are poor, especially because of the pervasive stigma associated with mental illness, with people who suffer from them, their families, and the institutions that are meant to help.

The report states that that the responsibility for change lies with governments, Ministries of Health, NGOs, consumers, caregiver organizations, private hospitals, community centers, media, patients and their families.

According to the report, mental disorders are linked to other health concerns that there can be no health without mental health.

Examples of such associated diseases are cardiovascular diseases, diabetes, HIV infection, maternal and child health, accidents and injuries.

In order to raise awareness about the need for change and improvement in the mental health domain and in people's perception of mental illness throughout the region, Eli Lilly and Company - Middle-East Affiliate worked with the World Federation of Mental Health to sponsor the translation of the report to Arabic and to make it accessible to all the communities across the Middle-East and the North-African regions.

By translating this report, the empowering messages and direction it provides are now accessible to doctors, people involved in the mental health field, as well as patients and their families.

This is a very practical guide with useful information that can help everyone speak in a unified voice about the need for improved services and advocate for greater community involvement.

In addition to the stigma associated with mental illness, the report also identifies other barriers that advocacy can help overcome.

This includes: the absence of mental health from public health agendas and its implication for funding; the current organization of mental health services; the lack of integration within primary care; the inadequate human resources for mental health; and the lack of public mental health leadership.

A recent multi-country survey that was supported by the WHO showed that 35-50% of serious cases in developed countries, and 76-85% in less-developed countries had received no treatment in the previous 12 months.

"Mental health is sorely misunderstood throughout the world, but even more so in this region," says Rima Maalouf, Corporate Communication Manager for Eli Lilly in the Middle-East and North Africa.

"Lilly is committed to the mental health field through its innovative products, as well as its medical and educational contributions to the mental health field both globally and regionally. In addition sponsoring translation of this report, Lilly also sponsors the 'Breaking Through Barriers' campaign - another World Federation of Mental Health initiative. This latter includes a website designed to provide all information related to depression and help patients, parents and caregivers break through the barriers of depression and achieve recovery."
Also consider reading:
Log in to request more information from Lilly

Notes and media contacts

Lilly:

Lilly is a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions